Lv21
120 积分 2025-02-08 加入
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
5小时前
已完结
The role of H3K27me3 methylation in cancer development
8天前
已完结
Epigenetic and transcriptional profiling of triple negative breast cancer
8天前
已完结
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer
8天前
已完结
H3K27me3-mediated regulation of PD-L1 expression in triple-negative breast cancer (TNBC)
8天前
已完结
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
8天前
已完结
A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin cleavable ADC linkers
9天前
已完结
Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)
18天前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
28天前
已完结
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
1个月前
已完结
皖公网安备34019202002308
